Malignant neoplasm of breast
|
0.300 |
Biomarker
|
disease |
CTD_human |
A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer.
|
29915430 |
2018 |
Breast Carcinoma
|
0.300 |
Biomarker
|
disease |
CTD_human |
A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer.
|
29915430 |
2018 |
Mammary Neoplasms, Human
|
0.300 |
Biomarker
|
disease |
CTD_human |
A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer.
|
29915430 |
2018 |
Mammary Neoplasms
|
0.300 |
Biomarker
|
group |
CTD_human |
A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer.
|
29915430 |
2018 |
Mammary Carcinoma, Human
|
0.300 |
Biomarker
|
disease |
CTD_human |
A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer.
|
29915430 |
2018 |
Secondary malignant neoplasm of bone
|
0.010 |
Biomarker
|
disease |
BEFREE |
This is the first instance where the genes ENO1, RPLP2, NME1-NME2 and CAPS1 were associated with disease severity and progression in LUAD patients with BM.
|
29522283 |
2018 |
Ulcerative Colitis
|
0.010 |
Biomarker
|
disease |
BEFREE |
The top-ranked IBD-associated PBMC differentially methylated region (promoter region of TRIM39-RPP2) was also significantly hypomethylated in colonic mucosa from paediatric UC patients.
|
26419460 |
2016 |
Inflammatory Bowel Diseases
|
0.010 |
GeneticVariation
|
group |
BEFREE |
The top-ranked IBD-associated PBMC differentially methylated region (promoter region of TRIM39-RPP2) was also significantly hypomethylated in colonic mucosa from paediatric UC patients.
|
26419460 |
2016 |
Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
To investigate the role of the P proteins in tumorigenesis, we examined the messenger RNA expression levels of Rplp0, Rplp1, and Rplp2 in a series of 32 patients with gynecologic tumors.
|
21040949 |
2011 |
Carcinogenesis
|
0.010 |
AlteredExpression
|
phenotype |
BEFREE |
To investigate the role of the P proteins in tumorigenesis, we examined the messenger RNA expression levels of Rplp0, Rplp1, and Rplp2 in a series of 32 patients with gynecologic tumors.
|
21040949 |
2011 |
Pancreatic Diseases
|
0.010 |
Biomarker
|
group |
LHGDN |
Upregulation of CD39/NTPDases and P2 receptors in human pancreatic disease.
|
16920697 |
2007 |
Benign neoplasm of breast
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
These data parallel our previous findings that the acidic ribosomal phosphoprotein P2 also has higher expression levels in the benign breast tumours (Sharp et al., 1990).
|
1370760 |
1992 |